Sedana Medical Annual Report 2017


Sedana Medical´s Annual Report for 2017 has been published and is available on www.sedanamedical.com.


For additional information, please contact:

Christer Ahlberg, CEO, Sedana Medical AB

+46 70 675 33 30

Christer.ahlberg@sedanamedical.com 

Maria Engström, CFO, Sedana Medical AB

+46 70 674 33 30

Maria.engstrom@sedanamedical.com 

Thomas Eklund, Chairman of the board, Sedana Medical AB

+46 70 824 20 25

Thomas.eklund@investorab.com 


Sedana Medical is listed on Nasdaq First North in Stockholm
and Erik Penser Bank (+46 8 463 83 00) is certified adviser to Sedana Medical. 


_________________________ 

Sedana Medical AB (publ) has developed and sells the medical device AnaConDa, for the administration of volatile anaesthetics to mechanically ventilated patients.

Sedana Medical has direct sales in the Nordic countries, Germany, France and Spain as well as external distributors in the rest of Europe, Middle East, Canada, Australia and South Korea. The company headquarters are based in Stockholm, Sweden with R&D operations in Ireland. 

Tags:

About Us

Sedana Medical AB (publ) has developed and sells the medical device AnaConDa, for the administration of volatile anaesthetics to mechanically ventilated patients.A major clinical registration study is currently ongoing to obtain market approval in Europe for inhalation sedation in intensive care units with the pharmaceutical IsoConDa® (isoflurane) Sedana Medical has direct sales in the Nordic countries, Germany, France and Spain as well as external distributors in the rest of Europe, Middle East, Canada, Australia and South Korea. The company headquarters are based in Stockholm, Sweden with R&D operations in Ireland.